<VariationArchive VariationID="832417" VariationName="NC_000005.10:g.(?_177288799)_(177288945_?)del" VariationType="Deletion" Accession="VCV000832417" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2020-04-15" MostRecentSubmission="2023-06-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819575" VariationID="832417">
      <GeneList>
        <Gene Symbol="NSD1" FullName="nuclear receptor binding SET domain protein 1" GeneID="64324" HGNC_ID="HGNC:14234" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177131798" stop="177300213" display_start="177131798" display_stop="177300213" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176560079" stop="176727213" display_start="176560079" display_stop="176727213" Strand="+" />
          </Location>
          <OMIM>606681</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_177288799)_(177288945_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q35.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="176715800" innerStop="176715946" display_start="176715800" display_stop="176715946" variantLength="147" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_176715800)_(176715946_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_176715800)_(176715946_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_177288799)_(177288945_?)del AND Beckwith-Wiedemann syndrome" Accession="RCV001032905" Version="8">
        <ClassifiedConditionList TraitSetID="1134">
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000005.10:g.(?_177288799)_(177288945_?)del AND Sotos syndrome" Accession="RCV003232186" Version="8">
        <ClassifiedConditionList TraitSetID="32529">
          <ClassifiedCondition DB="MedGen" ID="C0175695">Sotos syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-29" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2023-06-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12464997</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14571271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15942875</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16247291</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1134" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32529" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36672" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SOTOS SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral gigantism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHROMOSOME 5q35 DELETION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sotos' syndrome</ElementValue>
                <XRef ID="Sotos+syndrome/6665" DB="Genetic Alliance" />
                <XRef ID="75968004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sotos syndrome</ElementValue>
                <XRef ID="MONDO:0019349" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS117550" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SOTOS</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10091" />
                <XRef ID="10091" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Sotos syndrome is characterized by a distinctive facial appearance (broad and prominent forehead with a dolichocephalic head shape, sparse frontotemporal hair, downslanting palpebral fissures, malar flushing, long and narrow face, long chin); learning disability (early developmental delay, mild-to-severe intellectual impairment); and overgrowth (height and/or head circumference ≥2 SD above the mean). These three clinical features are considered the cardinal features of Sotos syndrome. Major features of Sotos syndrome include behavioral problems (most notably autistic spectrum disorder), advanced bone age, cardiac anomalies, cranial MRI/CT abnormalities, joint hyperlaxity with or without pes planus, maternal preeclampsia, neonatal complications, renal anomalies, scoliosis, and seizures.</Attribute>
                <XRef ID="NBK1479" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301652</ID>
                <ID Source="BookShelf">NBK1479</ID>
              </Citation>
              <XRef ID="821" DB="Orphanet" />
              <XRef ID="C0175695" DB="MedGen" />
              <XRef ID="MONDO:0019349" DB="MONDO" />
              <XRef Type="MIM" ID="117550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357468" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4292421|MedGen:C0004903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196212" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 21 of the NSD1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with NSD1-related conditions. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_176715800)_(176715946_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0004903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3109006" SubmissionDate="2023-02-03" DateLastUpdated="2023-06-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_022455.4_5_Deletion (exon 21)|MedGen:C4551477" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583369" DateUpdated="2023-06-10" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12464997</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14571271</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15942875</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16247291</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 21 of the NSD1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with NSD1-related conditions. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_176715800)_(176715946_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4551477" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357468" TraitType="Disease" MappingType="Name" MappingValue="Beckwith-Wiedemann syndrome" MappingRef="Preferred">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

